Protagonist Therapeutics Inc (PTGX)
R&D Expense Growth
-10.01%
Quarterly · Period ending:
PTGX R&D Expense Growth
Latest reported-10.01%period ending
Latest reported-10.01%period ending
PTGX Quarterly R&D Growth (QoQ) (0.00% → -10.01%)
Latest values, visible window
High-resolution chart · PNG
PTGX r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -10.0088% | |
| 0.8219% | |
| 15.8863% | |
| 8.0111% | |
| 3.1845% | |
| 2.8335% | |
| -2.9636% | |
| 7.3091% | |
| -0.6344% | |
| 16.7307% | |
| -5.7559% | |
| -7.5885% | |
| 21.0315% | |
| -8.2586% | |
| 17.6443% | |
| -26.6071% | |
| -4.7001% | |
| -7.5243% | |
| 6.2696% | |
| 34.7923% | |
| 9.3487% | |
| 24.5801% | |
| 25.8268% | |
| -21.0396% | |
| 7.9337% | |
| 17.9561% | |
| -7.9917% | |
| -10.6536% | |
| 55.5368% | |
| -12.6614% | |
| 17.3158% | |
| -31.5196% | |
| 15.4021% | |
| 31.0815% | |
| 4.9785% | |
| -6.9876% | |
| 6.4262% | |
| 27.8703% | |
| 58.6585% | |
| -2.3701% | |
| 1.2622% | |
| 34.1522% | |
| 32.7739% | |
| 37.4837% | |
| 5.2222% | |
| 0% |